Abstract-Oxidative stress and the production of intracellular reactive oxygen species (ROS) have been implicated in the pathogenesis of a variety of diseases. In excess, ROS and their byproducts that are capable of causing oxidative damage may be cytotoxic to cells. However, it is now well established that moderate amounts of ROS play a role in signal transduction processes such as cell growth and posttranslational modification of proteins. Oxidants, antioxidants, and other determinants of the intracellular reduction-oxidation (redox) state play an important role in the regulation of gene expression. Recent insights into the etiology and pathogenesis of atherosclerosis suggest that this disease may be viewed as an inflammatory disease linked to an abnormality in oxidation-mediated signals in the vasculature. In this review, we summarize the evidence supporting the notion that oxidative stress and the production of ROS function as physiological regulators of vascular gene expression mediated via specific redox-sensitive signal transduction pathways and transcriptional regulatory networks. Elucidating, at the molecular level, the regulatory processes involved in redox-sensitive vascular gene expression represents a foundation not only for understanding the pathogenesis of atherosclerosis and other inflammatory diseases but also for the development of novel therapeutic treatment strategies.
ukaryotic cells have evolved highly elaborate mechanisms to rapidly respond to changes in their environment by altering the expression of genes. Various forms of cellular stress constitute primary signals that are transduced into the cytoplasm and ultimately alter the expression of specific genes in the cell nucleus. One such form of cellular stress is the production of oxygen free radicals or reactive oxygen species (ROS). Historically, ROS have been implicated in a variety of distinct cellular stresses including heat shock, ionizing and UV irradiation, and a variety of oxidizing pollutants such as tobacco smoke and ozone. In addition, inflammatory cells such as neutrophils and macrophages have evolved a mechanism to use ROS in host defense. These cells release intracellular hydrogen peroxide (H 2 O 2 ) and superoxide in response to invading organisms in large amounts that are generally toxic to the invading microorganisms. Recently, however, many other cell types, such as fibroblasts, endothelial cells (ECs), and smooth muscle cells (SMCs), have been shown to produce ROS at relatively low levels in response to cellular "activation" signals. In contrast to the view that oxidative stress and ROS are damaging to the cell, it has been proposed that ROS in these cells play a role as second messengers to regulate signal transduction pathways that ultimately control gene expression and posttranslational modifications of proteins. ROS have been implicated in a variety of diseases, including Alzheimer disease, cancer, and vascular diseases such as atherosclerosis. The focus of this review is to summarize the current literature supporting the notion that ROS in the vasculature function as physiological regulators of gene expression by modulating specific redoxsensitive signal transduction pathways and transcriptional regulatory events.
EC Dysfunction and Atherosclerosis
Atherosclerosis is a complex, multifactorial disease in which the cellular and molecular mechanisms contributing to the disease process are poorly defined. Recent insights into the pathogenesis of atherosclerosis suggest that it may be viewed as a chronic inflammatory disease with an underlying abnormality in redox-mediated signals in the vasculature. [1] [2] [3] In a normal, healthy state, the vessel wall is composed of a single-cell-thick EC lining that exhibits intimate contact with the medial layer of vascular SMCs (VSMCs). Encircling this is the adventitial layer consisting of a dense matrix of connective tissue. As such, the EC is optimally situated at the interface between the circulating blood and the vessel wall to serve as a sensor and transducer of signals within the circulatory microenvironment. Therefore, the EC is integral in maintaining the homeostatic balance of the vessel through the production of factors that regulate vessel tone, coagulation state, cellular proliferative response, and leukocyte trafficking. In vascular disease, however, EC dysfunction occurs when the cell loses its ability to maintain the normal homeostatic balance, ultimately leading to impairment in vasorelaxation and increased adhesiveness of the EC lining for circulating inflammatory cells. 3 EC dysfunction is central to the pathogenesis of atherosclerosis. Although the precise cellular and molecular processes involved in the pathogenesis are unknown, atherosclerosis is generally viewed as a chronic inflammatory disease of the arterial intima characterized by the formation of the atherosclerotic plaque, which is a focal accumulation of mononuclear leukocytes, SMCs, lipids, and extracellular matrix components. 3, 4 One of the earliest detectable events in the generation of atherosclerosis is the infiltration of inflammatory cells to discrete segments of the arterial wall and their transformation into lipid-laden macrophages (foam cells). The initial recruitment of leukocytes into the lesion is mediated by an increased gradient in chemotactic factors released from the endothelium or SMCs by various inflammatory stimuli. Accumulating evidence suggests that these inflammatory signals and other "proatherogenic" stimuli result in the production of ROS within the endothelial microenvironment. As discussed below, several lines of investigation suggest that the production of ROS and the resultant oxidative stress play a key role in mediating the pathologic manifestations of EC dysfunction associated with atherosclerosis.
Oxidative Signaling and Vascular Inflammatory Gene Expression
Hyperlipidemia, diabetes, hypertension, and smoking are well-established risk factors for the development of atherosclerosis. However, the molecular and cellular mechanisms linking these diverse risk factors to a common pathologic mechanism are unclear. A current hypothesis suggests that modulation of the expression of a selective set of vascular inflammatory genes by intracellular oxidative signals may provide a molecular mechanism linking these seemingly diverse risk factors with the early pathogenesis of atherosclerosis ( Figure 1 ). 5, 6 As such, various proinflammatory or prooxidant stimuli associated with these risk factors may directly stimulate or sensitize vascular cells to generate ROS. These ROS and/or their modified target biomolecules (ie, oxidized LDL) then serve as true second-messenger coupling molecules to transmit these extracellular signals to elevated expression of atherogenic gene products such as adhesion molecules and other vascular inflammatory gene products. The induced expression of these gene products thus promotes the infiltration of monocytes into the vessel wall and the release of additional proinflammatory signals. Accordingly, this positive feedback loop would serve to potentiate the local inflammatory response and EC dysfunction. Conversely, chemical or cellular antioxidants would protect vascular cells against oxidative stress by scavenging ROS generated from the inflammatory stimuli and altering the oxidative milieu or by directly modulating redox-sensitive signaling pathways and blocking atherogenic gene expression. Consistent with this hypothesis is the observation that the expression of vascular inflammatory gene products such as vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) by diverse proinflammatory stimuli occurs through a redox-sensitive mechanism involving the redox-regulated transcription factor nuclear factor-B (NF-B). [7] [8] [9] Thiol antioxidants such as pyrrolidine dithiocarbamate (PDTC) and N-acetylcysteine (NAC) and other chemically distinct antioxidants (our unpublished observations, 1998) inhibit cytokine-inducible expression of both VCAM-1 and MCP-1 in ECs. Thus, ROS may act as specific regulators in the signal transduction network to relay environmental and physical signals generated at the cell membrane to nuclear regulatory signals resulting in modulation of inflammatory gene expression. In the following sections, we will discuss the current state of the literature with respect to understanding the following: (1) the association of selected atherogenic risk factors with oxidative stress, (2) specific transcriptional regulatory factors and signaling events modulated by an altered redox environment in the vasculature, and (3) the functional implications of redoxsensitive modulation of gene expression in the vasculature with respect to the pathogenesis of atherosclerosis.
Atherogenic Risk Factors as Mediators of Oxidative Stress
A variety of pathophysiological processes involved in atherosclerosis such as hyperglycemia, hypertension, hyperlipidemia, and local hemodynamic stresses are known to mediate elevated levels of ROS in the vasculature. However, mam- Various cellular processes that may be influenced by nutrition and therapeutic intervention regulate the relative level of intracellular oxidative stress. Relatively high levels of oxidative stress result in the induction of vascular inflammatory ("atherogenic") genes via redox-sensitive signaling pathways and activation of redox-sensitive transcription factors. Relatively lower levels of oxidative stress maintain a noninflammatory or vascular protective effect via the induction of "atheroprotective" genes. Thus, ROS produced as a result of an oxidative stress may act as specific regulators in the signal transduction network to relay environmental and physical signals generated at the cell membrane to nuclear regulatory signals, resulting in modulation of inflammatory gene expression.
malian cells are protected from ROS by antioxidant defense mechanisms such as the enzymes catalase, superoxide dismutase (SOD), and glutathione peroxidase (GPx). When the normal redox homeostasis of the cell is upset and the rate of formation of ROS exceeds the capacity of the antioxidant defense system, a condition of oxidative stress occurs. Despite the experimental evidence implicating redox processes and oxidative stress in the pathogenesis of atherosclerosis, little is known about the relative role of each of the potential sources for ROS production in the vasculature. It is beyond the scope of this review to provide a detailed examination of the sources and mechanisms involved in ROS production; this topic has been reviewed in detail elsewhere (References 10 and 11 and references therein). Rather, we will only briefly discuss the contribution of selected atherogenic risk factors to cellular redox control and the involvement of selected sources of ROS in the vasculature as they relate to their potential involvement in mediating redox-sensitive gene expression.
There are a variety of intracellular sources for free radicals and ROS that have been identified (Table) . These include, but are not limited to, normal products of mitochondrial respiration, NADPH oxidase, nitric oxide (NO) synthases, cyclooxygenases, lipoxygenases, cytochrome P-450 monooxygenase, and xanthine oxidase. 10, 11 Via the action of these enzymatic sources and the autoxidation of various soluble cellular biomolecules, eukaryotic cells continuously produce ROS, including superoxide anion (O 2 ⅐ Ϫ ), hydrogen peroxide (H 2 O 2 ), and hydroxyl radicals (OH⅐). The literature supporting the involvement of various sources of ROS and the nature of individual reactive species has been generalized from many different in vitro and in vivo systems. The role of any of these sources as they relate to ROS production is not well established for cell types of the vasculature. Furthermore, the relative contribution of any of these to the pathogenesis of diseases of the vasculature is not well established, and their relative role will likely vary with cell type and physiological state of the cell.
Although the identity of the ROS-generating systems in the vasculature is not clear, evidence suggests that NADPH oxidase-like activity appears to be a contributing source of ROS via the generation of superoxide anion in both cultured ECs 12, 13 and VSMCs, 14 as well as in intact aortas. 15 Molecular and enzyme inhibition studies suggest that the enzyme responsible for superoxide production in the vasculature is similar to the phagocyte-type NADPH oxidase 13,16 -19 ; however, the precise molecular identity of the oxidase is not known. Furthermore, given that the lucigenin assay (which is routinely used to measure NADPH production of superoxide) has been a subject of controversy because of its ability to spontaneously generate superoxide under certain assay conditions, care should be taken in drawing conclusions about the role of NADPH in superoxide production in studies using this assay.
Cytokines and growth factors such as tumor necrosis factor-␣ (TNF-␣), interleukin (IL)-1␤, angiotensin II (Ang II), and interferon-␥ activate membrane-bound NADPH oxidase to produce superoxide in ECs. 12, 14, 19, 20 Diphenylene iodonium, an inhibitor of NADPH oxidase, has been shown to abrogate superoxide production in response to TNF-␣ in ECs. 21 The notion that ROS generated via an NADPH oxidase activity may function as signaling molecules to modulate vascular gene expression is supported by the observation that NADPH oxidase inhibitors block cytokineinduced VCAM-1 and intercellular adhesion molecule-1 (ICAM-1) gene expression in human aortic ECs 21 and attenuate Ang II-mediated activation of VCAM-1 and MCP-1 in VSMCs. 22 Consequently, the generation of ROS via NADPH oxidase activity in response to proinflammatory stimuli may regulate the expression of a variety of redox-sensitive genes in the vasculature.
The ROS NO is produced by a variety of cell types, including ECs, macrophages, SMCs, and fibroblasts and has been shown to be an important factor in the regulation of many biological responses. NO produced by the endothelium modulates vasomotor tone, inhibits platelet aggregation, and inhibits SMC proliferation, properties that have been shown to be antiatherogenic. 23 Several studies have demonstrated NO regulation of vascular inflammatory gene expression, including that of VCAM-1 24, 25 and MCP-1. 26, 27 Furthermore, several studies have demonstrated that NO levels modulate the activity of cytokine-activated NF-B in ECs, 24, 27, 28 thus providing a potential mechanism for NO suppression of vascular gene expression. NO may modulate gene expression by altering the intracellular oxidative environment. On the basis of the cell type or concentrations present, NO has been shown to both augment 29, 30 and inhibit 31, 32 oxygen radicalmediated tissue damage and lipid peroxidation. NO has been shown to (1) reduce superoxide generation, 26, 33 (2) inhibit oxidation of LDL and delay the formation of lipid peroxides, 34 and (3) redirect the reactivity of partially reduced oxygen species. 35 On the other hand, NO can react with superoxide to produce peroxynitrite anion (ONOO Ϫ ), which is a potent oxidant. 36 In fact, although ONOO Ϫ itself is a highly reactive free radical, it is possible that ONOO Ϫ could subsequently nitrosylate sulfhydryl groups to form S-nitrosothiols. 37 Therefore, NO exhibits a dual redox func- tion that is based on its interaction with other ROS. Thus, through direct modulation of intracellular oxidative stress, NO can modulate signaling pathways (such as those involved in NF-B activation) and regulate the expression of vascular inflammatory genes such as VCAM-1 and MCP-1.
Hypertension and Ang II
Hypertension is an established risk factor for the development of vascular disease, and both clinical and experimental evidence support a potential role of the renin-angiotensin system in contributing to the pathogenesis of hypertensionassociated atherosclerosis. 6 Recent studies have supported a role for Ang II in the generation of oxidative stress in the vasculature via the induction of superoxide via NADPH oxidase. 14 In addition, Ang II has been shown to stimulate the increase of both MCP-1 and VCAM-1 mRNA expression in rat aortas. 38 In these experiments, the increased expression of both VCAM-1 and MCP-1 by Ang II could be blocked by NADPH oxidase inhibitors and catalase, suggesting that NADPH oxidase may be contributing to oxidative stress and regulation of vascular inflammatory genes via the generation of H 2 O 2 . Thus, Ang II, through the formation of oxidative stress and increased levels of proinflammatory genes in the vessel wall, may serve as a molecular link between hypertension and the pathogenesis of atherosclerosis.
Hyperglycemia
Other established risk factors for the development of vascular disease are complications related to diabetes as a consequence of hyperglycemia. Diabetes-associated hyperglycemia produces an intracellular oxidative stress that leads to vascular dysfunction. 39 It has been documented that relatively high concentrations of glucose stimulate superoxide generation and enhance cell-mediated LDL peroxidation in ECs. 40, 41 In addition, incubation of ECs with high concentrations of glucose result in an increased activation of the redoxsensitive transcription factor NF-B, 42 suggesting that hyperglycemia may activate endothelial gene expression via activation of NF-B. Advanced glycation end products (AGEs) are posttranslational modifications of cellular proteins believed to play a role in the vascular complications associated with diabetes. 43 Interaction of AGEs with cell surface receptors (RAGEs) has been shown to generate ROS, decrease the levels of reduced glutathione, and activate NF-B. 44, 45 Chronic AGE accumulation in animals promotes VCAM-1 expression and formation of atherosclerotic lesions in the absence of hyperglycemia. 46 In addition, AGE-induced expression of VCAM-1 and monocyte/endothelial interactions can be blocked by antioxidants. 46 These observations suggest that pathogenic processes associated with diabetes may result in modulation of the intracellular redox state and expression of redox-sensitive inflammatory genes in the vessel wall.
Modified LDL
One of the earliest events in atherosclerosis is the oxidative modification of lipoproteins (in particular, LDL) in the vessel wall. The role of oxidatively modified LDL (oxLDL) as an important oxidative signal in the pathogenesis of atherosclerosis has been well established. 5, 47 oxLDL is a complex structure consisting of several chemically distinct oxidants. oxLDL alters the intracellular redox status of the cell in part through the generation of superoxide 48 and has been implicated as an important prooxidant signal in the pathogenesis of atherosclerosis. 5 Although controversial, several studies suggest that oxLDL or fatty acid hydroperoxides (one of the more abundant components of oxLDL) act as prooxidant signals to regulate monocyte adhesion, vascular gene expression such as ICAM-1 and VCAM-1, 49, 50 and redox-sensitive transcriptional factors such as activator protein-1 (AP-1) 51 and NF-B. [52] [53] [54] Although the concentrations of oxLDL used in some of these studies may be greater than that predicted to occur in circulating serum, it has been suggested that in vivo, LDL accumulates and is oxidized in a localized microenvironment that is relatively sequestered from plasma antioxidants. 5, 55 In contrast to the effects of oxLDL, nonmodified (native) LDL has also been shown to induce adhesion molecule expression on ECs. 56, 57 Therefore, the role of oxidation of the LDL particle and the exact nature of the chemical oxidants in mediating endothelial/leukocyte adhesion is an area for additional investigation.
Also controversial is the enzymatic source of LDL oxidation. It has been proposed that cellular lipoxygenases (LOs) may mediate LDL oxidation and the formation of fatty acid hydroperoxides in several cell types. Increased levels of 15-LO activity have been detected in atherosclerotic lesions in rabbit and human aorta compared with normal arteries. 58, 59 Furthermore, transient overexpression of 15-LO enhances TNF-␣-induced VCAM-1 expression, 60 and 5-LO inhibitors blocked IL-1␤-induced VCAM-1 expression in ECs. 61 Together, these studies suggest a role for oxLDL as a prooxidant signal that modulates the expression of redox-sensitive inflammatory gene products. As of yet, the exact nature of the cellular signals that lead to the generation of oxidized lipids are not known, although LOs likely play a key role.
Hemodynamic Forces
Vascular ECs are constantly subjected to the influence of hemodynamic forces including shear stress imposed by blood flow. The localization of atherosclerotic lesions to areas of low shear stress has led to the hypothesis that local hemodynamic forces may contribute to the focal nature of early atherosclerotic lesion development. 62 The effects of fluid shear stress on endothelial biology and gene expression have been extensively studied (for review, see References 63 and 64), and one of the biological effects is alteration of EC/ leukocyte interactions. This altered adhesivity of leukocytes for the EC is caused, at least in part, by the regulation of the adhesion proteins ICAM-1 and VCAM-1.
Several studies have demonstrated that increased blood flow and fluid shear stresses alter the EC redox state and redox-sensitive gene expression. [65] [66] [67] [68] [69] Laurindo et al 65 provided both ex vivo and in vivo evidence that increases in blood flow lead to increased intracellular free radical release. In these studies, electron paramagnetic resonance spectroscopy was used to show that perfusion of isolated aortas led to increased levels of free radicals only in aortas containing an intact endothelium. This effect was completely blocked by addition of SOD, an antioxidant enzyme that accelerates the conversion of superoxide to H 2 O 2 . Similar effects were observed with in vivo-induced changes in blood flow. Hsieh et al 67 demonstrated that exposure of ECs to a steady laminar shear stress resulted in an increase in intracellular ROS and expression of the redox-sensitive transcription factor c-fos. These changes were abolished by treatment with the antioxidant NAC or catalase. Similar results were observed by Chiu et al, 68 who demonstrated that shear stress-induced elevations of intracellular superoxide levels and ICAM-1 mRNA and promoter activities could by blocked by NAC and SOD.
De Keulenaer et al 66 showed that oscillatory shear stress induced the expression of NADH oxidase (a major source of ROS in the vasculature), superoxide, and the redox-sensitive gene heme oxygenase-1 in cultured ECs. These effects could be blocked by pretreatment with the antioxidant NAC. In contrast, application of steady laminar shear induced only a transient increase in NADH oxidase and lower levels of superoxide. The authors suggest that steady laminar shear may induce compensatory antioxidant defense mechanisms by the observed increased expression of SOD, an antioxidant defense enzyme of which the level of expression adapts to changes in oxidative stress. Similar increases in SOD expression by shear stress were observed in human arterial ECs 70 and human umbilical vein ECs. 71 The notion that steady laminar shear stress may play a protective role in vasculature is supported by the observation that steady unidirectional shear stress decreases the basal and cytokine-induced expression of VCAM-1 in human ECs. 72, 73 Furthermore, steady laminar shear preconditioned ECs exhibited a reduced synthesis of fatty acid hydroperoxides compared with static control cells (S.E. Varner and R.M. Medford, unpublished observations, 1997).
In addition to the generation of ROS, it is well known that shear stress is also a potent stimulus for endothelial synthesis of NO. 74, 75 This may be caused, in part, by an increase in EC NOS steady-state mRNA levels 71, 76 and may be mediated by activation of c-Src-dependent serine kinase by shear stress. 77 Tsao et al 72 have shown that NO mediates the steady shear stress inhibition of oxLDL and lipopolysaccharide/TNF-␣-induced superoxide production, NF-B activation, VCAM-1 expression, and endothelial-monocyte adhesion. Therefore, given the recent evidence that NO may reduce intracellular oxidative stress, 26, [33] [34] [35] elaboration of NO may be one mechanism by which ECs modulate the level of intracellular oxidative stress and regulate redox-sensitive gene expression in response to changes in endothelial shear stresses. Cumulatively, these data support the notion that differences in EC redox state, which may be modulated by different types of shear stresses, may contribute to altered endothelial gene expression and contribute to the focal nature of atherosclerosis.
Redox-Sensitive Transcriptional Signaling Pathways
The notion that oxidative stress can modulate a wide variety of biological processes by coupling signals at the cell surface into long-term changes in gene expression suggests that multiple signaling pathways are involved. 83 Thus, evidence exists to suggest the potential involvement of ROS-mediated Ca 2ϩ flux in early signaling pathways; however, the exact mechanisms remain to be elucidated.
Protein Phosphorylation
Phosphorylation of proteins is, in most cases, the penultimate event in the signaling cascade leading to changes in gene expression. Transcription factors or their interacting proteins are frequently the direct target of phosphorylation modifications that either stimulate or inhibit their activity. The most-well studied classes are the serine/threonine kinase/ phosphatases and tyrosine kinase/phosphatases. It has been estimated that there are upwards of 2000 distinct protein kinases and 1000 protein phosphatases in the mammalian genome. 87 Therefore, it is not surprising that experimental evidence is beginning to emerge implicating multiple protein kinase/phosphatase pathways in redox-mediated signaling events.
Tyrosine Kinases
Stimulation of tyrosine kinase activity by oxidants or agents that induce oxidative stress has been observed by a number of laboratories in a variety of cell types (reviewed in Reference 78). For example, ionizing radiation and H 2 O 2 , agents that induce oxidative stress, have been demonstrated to induce tyrosine phosphorylation events and activate downstream kinases such as protein kinase C, p56 lck, and p72raf1. 88 -90 Sundaresan et al 91 demonstrated that stimulation of VSMCs by platelet-derived growth factor transiently increases intracellular H 2 O 2 production, resulting in tyrosine phosphorylation, activation of mitogen-activated protein kinase (MAPK) activity, and chemotaxis. These effects were blocked by increasing the intracellular concentration of the free radical scavenging enzyme catalase or by NAC. These results suggest a direct role for H 2 O 2 as a signal-transducing molecule via modulation of a tyrosine phosphorylation event. Because many growth factor receptors (such as platelet-derived growth factor) are themselves tyrosine kinases, these membrane-associated signaling molecules are well situated to monitor the peroxidation state of lipid bilayers, a sensitive reflection of cellular redox status. Indeed, it has been shown that the redox responsiveness of some tyrosine kinase receptors is ligand independent. 92, 93 It is not yet clear whether ROS cause direct activation of tyrosine kinase activity or the observed increases in tyrosine phosphorylation are caused by inhibition of tyrosine phosphatase activity by oxidant-mediated signals. Because all tyrosine phosphatases have reactive cysteine residues in their active sites, it has been proposed that inhibition of tyrosine phosphatase activity by oxidants may account for the mechanisms of stimulation of tyrosine phosphorylation by oxidant stimuli. 78 In this regard, it has been reported that the oxidizing agents phenylarsine oxide 94 and H 2 O 2 95,96 inhibit tyrosine phosphatase activity. Similarly, PKC-mediated serine/threonine phosphorylation in response to oxidative stress may be the result of inhibition of protein phosphatase 1 and 2A activity, given that thiol oxidation in these phosphatases has been shown to inhibit the enzyme activity. 78 Consequently, the activation of a signal transduction pathway in response to oxidative stress may be mediated by inhibitory activities of oxidants at the molecular level.
Mitogen-Activated Protein Kinases
MAPKs play a role in relaying signals from extracellular stimuli to the cell nucleus, where they are often the ultimate regulatory proteins in a series of sequential kinase reactions that target transcription factor modification. The MAPK family consists of the extracellular signal-regulated kinases (ERK) subgroup, the stress-activated protein kinase, or c-jun N-terminal kinase (SAPK/JNK) subgroup, and the p38 MAPK subgroup. One of the better-characterized functional targets of the MAPK family is the transient phosphorylation of the transcription factor complex that regulates the c-fos promoter. Another is the phosphorylation and subsequent activation (by the SAPK/JNK family) of the transcriptional activation domain of c-jun. As discussed below, both c-jun and c-fos are components of the well-characterized redoxsensitive transcription factor AP-1. Although not the focus of this review, considerable experimental evidence supports the notion that changes in the cellular redox state by either an induction of an oxidative stress or administration of antioxidants activate signaling pathways involving various members of the MAPK family. 78, 97 Although MAPK regulation by ROS and antioxidants is often demonstrated, it is important to remember that these kinases are downstream in the signal transduction pathways. Therefore, it is difficult to assess the direct contribution of ROS on the modulation of MAPK activity. Redox modulation of their activity may reflect more direct effects on upstream signaling processes that ultimately converge on the MAPKs.
Several reports have begun to address the involvement of the MAPK signaling pathway in redox-mediated signaling in the vasculature. Initially, Baas and Berk 98 demonstrated that addition of the superoxide-generating agent LY83583 to VSMCs resulted in a concentration-dependent increase in MAPK activity. Various physiological agents believed to play a role in vascular dysfunction, including oxLDL, 99 Ang II, 100 lactosylceramide (Lac-Cer), 101 and linoleic acid and its metabolites, 84 have been shown to activate MAPK activity in VSMCs via the generation of intracellular ROS. Ushio-Fukai et al 100 demonstrated that Ang II elicited an increase in intracellular H 2 O 2 and a rapid phosphorylation of both p42/44 MAPK and p38 MAPK. Inhibitors of NADPH oxidase and overexpression of catalase blocked Ang II-mediated phosphorylation of p38 MAPK. Also, Lac-Cer, a ubiquitous glycosphingolipid implicated in the proliferation of SMC and found at high concentrations in atherosclerotic plaques, was shown to stimulate endogenous superoxide production in aortic SMCs by activation of NADPH oxidase. 101 The increase in superoxide production resulted in activation of the MAPK pathway and ultimately induction of c-fos and cell proliferation. Alteration of the cellular redox status by treatment with the antioxidants PDTC and NAC inhibited LacCer-generated superoxide and blocked the phosphorylation/ activation of p44 MAPK. Also, in human umbilical vein ECs, H 2 O 2 activated p38 MAPK activity with an associated marked reorganization of the stress-fiber network associated with the assembly of vinculin to focal adhesions. 102 A specific inhibitor of p38 MAPK activity (SB203580) blocked the H 2 O 2 -induced microfilament responses, suggesting that p38 MAPK is a critical redox-sensitive pathway functioning in the reorganization of endothelial microfilament network.
Hypoxia and reoxygenation impose 2 extremes of redox stress on cardiac tissue and are principal components of myocardial ischemia and reperfusion. Reperfusion of ischemic tissue is associated with cell injury caused by ROS that are generated by reoxygenation. These ROS cause cell damage directly, by oxidation of cellular components, and also indirectly, by the activation of localized inflammation [103] [104] [105] [106] likely via the action of redox-sensitive signaling pathways resulting in increased inflammatory gene expression. Although the signals and pathways that mediate the response of cardiac myocytes to this type of redox stress are unclear, several groups have demonstrated direct effects of hypoxia/reoxygenation in cardiac myocytes on both the SAPK/JNK and p38 MAPK pathways 97, [107] [108] [109] [110] and have shown that both p38 MAPK and SAPK/JNK activity is strongly attenuated by preincubation of the cells with antioxi-dants and tyrosine kinase inhibitors. 97 Cumulatively, these results implicate unquenched ROS as a stimulus that initiates MAPK signaling pathways in the vasculature and provide a molecular link to physiological stimuli that alter intracellular ROS levels and changes in gene expression and cellular function.
Redox Modulation of Transcription Factor Activity
The hypothesis that redox-sensitive signaling pathways regulate vascular inflammatory gene expression suggests that ultimately, specific DNA binding proteins, or transcription factors, will be the target of such a signaling cascade. Transcription factors are central to any discussion of gene regulation, as they are the nuclear components that are modulated by upstream signaling events. By virtue of their ability to interact with very specific DNA sequences (which are unique to each transcription factor) in the regulatory regions of genes, transcription factors serve to modulate not only the magnitude of gene expression, but also the specificity of the signal. This specificity is determined in part by the presence or absence of a binding site in the promoter region of the target gene. Theoretically, redox-sensitive modulation of transcription factor activity can occur via (1) direct oxidative modification of the transcription factor itself by intracellular ROS or (2) posttranslational modifications (ie, phosphorylation/dephosphorylation), by the effects of redoxregulated intracellular signaling cascades. Either mechanism can potentially affect various aspects of transcription factor function, such as subcellular localization, DNA binding properties, and inherent transcriptional activity. The activity of many eukaryotic transcription factors has been reported to be modulated by redox changes by one of the above mechanisms and has been summarized in several excellent reviews. 78, [111] [112] [113] Many of the reported studies demonstrate changes in the in vitro DNA binding activity of transcription factors in response to oxidants or reductants. Generally, highly conserved cysteine residues in the DNA binding regions of these proteins have been shown to be targets of redox modulation. These in vitro studies have generally shown that reducing environments increase, whereas oxidizing conditions inhibit, sequence-specific DNA binding. However, when intact cells have been used for study, it is generally observed that oxidizing agents activate and reducing conditions inhibit transcription factor activity. These observations present an intriguing paradox and suggest that in vivo more complex regulatory networks mediated by ROS impart redox control of transcription factor activity. It is likely that transcription factor activity depends not only on direct protein modification by intracellular ROS, but also on posttranslational modifications to the transcription factor as a result of redox-sensitive signaling pathways. Although redox regulation of many transcription factors has been documented, 113 we will focus on the 2 most well-characterized transcription factors subject to redox regulation in the vasculature, NF-B and AP-1, and will discuss recent evidence implicating the potential role of the peroxisome proliferatoractivated receptor (PPAR) family of transcriptional activators in oxidative stress.
Redox Regulation of AP-1
NF-B and AP-1 are the most well-studied transcriptional factors influenced by the cellular redox state. 111, 113 They have been implicated in transcriptional regulation of a wide range of genes involved in cellular inflammatory responses, tissue destruction, and growth control. Homodimers and heterodimers of members of the c-jun and c-fos proto-oncogene families constitute the transcription factor AP-1. At least 3 mammalian Jun proteins (c-Jun, Jun B, and Jun D) and 4 Fos family members (c-Fos, Fra-1, Fra-2, and Fos B) have been identified (reviewed in Reference 114). All of the Jun family proteins are capable of forming homo-and heterodimers that are capable of binding to AP-1 DNA binding sites. Fos proteins do not associate with each other but are capable of associating with any member of the Jun family to form stable heterodimers that have higher DNA binding activity than Jun-Jun homodimers. 115 Both the Jun:Jun and Fos:Jun forms of AP-1 bind to a specific DNA sequence (the tissue-type plasminogen activator-responsive element, TRE) in promoters of many inducible genes. The promoter for the c-jun gene contains a TRE and is primarily activated by AP-1 in a positive autoregulatory fashion. 114, 116 The promoter for c-fos, however, does not contain a TRE and thus is not subject to autoregulation by AP-1.
The activity of AP-1 is controlled by both transcriptional and posttranslational mechanisms in response to a variety of extracellular stimuli, including mitogens, phorbol esters, and differentiation signals. In addition, AP-1 behaves as a redoxsensitive transcription factor in several cell types and is activated, to different extents, under prooxidant conditions generated by treatment with agents such as superoxide, H 2 O 2 , UV light, ␥-irradiation, and cytokines. [117] [118] [119] [120] [121] In cell types of the vasculature, AP-1 is similarly activated by prooxidant stimulus. In ECs, agents such as H 2 O 2 , 122 LDL, 123 and oxLDL 124 activate AP-1 DNA binding activity. In SMCs, oxLDL, 125 H 2 O 2 , 126 and the lipid peroxidation product 4-hydroxy-2-nonenal 127 have been shown to increase AP-1 expression or DNA binding activity. Furthermore, regulation of the vascular inflammatory genes MCP-1 and ICAM-1 by H 2 O 2 is mediated by AP-1 binding elements in the promoters of these genes. 128, 129 Little information is known about the exact mechanisms underlying ROS-mediated AP-1 activation; however, roles of phospholipase A 2 , arachidonic acid, LO, and protein kinase C have been proposed for H 2 O 2 induction of c-fos 130 and c-jun 131 expression in VSMCs. In addition, H 2 O 2 -induced AP-1 activation requires both tyrosine and serine/threonine phosphorylation, 132 and it has been suggested that AP-1 activation under oxidative conditions may be, at least in part, mediated by phosphorylation of Jun proteins. 133 Therefore, it appears that posttranslational modifications after oxidative stress may modulate AP-1 activity.
The nuclear redox factor Ref-1 was initially cloned as a molecule that stimulated DNA binding of AP-1 via reduction of the conserved cysteine residues. 134 Initially identified in HeLa nuclear extracts, Ref-1 has subsequently been shown to be ubiquitous and can stimulate DNA binding of other eukaryotic transcription factors in addition to AP-1. 135 Thioredoxin (TRX) is another pleiotropic cellular factor that has thiol-mediated redox activity and functions to facilitate protein-nucleic acid interactions. TRX has also been shown to enhance the DNA binding activity of Jun and Fos via direct interaction with Ref-1. 136 Paradoxically, in addition to oxidative stress, a number of antioxidants, including dithiocarbamates, the antioxidant enzyme TRX, and NAC have also been shown to stimulate the DNA binding and transcriptional activity of AP-1 in several cell types. 133 In monocytic cells, the upregulation of the ␤ 2 integrin CD11c by PDTC was shown to involve a functionally important AP-1 site and correlated with increased levels of AP-1 DNA binding by PDTC. 137 Similarly, PDTC-induced ICAM-1 expression correlated with increased AP-1 binding to the PDTC-responsive region of the ICAM-1 promoter in ECs. 138 Paradoxically, antioxidants have also been shown to block AP-1 transcriptional activity in ECs. The antioxidant enzyme TRX peroxidase-1 blocked TNF-␣-induced AP-1 activation in ECs. 139 Wung et al 128 demonstrated that cyclic strain and H 2 O 2 -induced MCP-1 gene expression in ECs was mediated by an AP-1 element in the MCP-1 promoter. NAC and catalase prevented cyclic strain-or H 2 O 2 -induced AP-1 binding and MCP-1 expression. Thus, conflicting evidence exists over the role of antioxidants in AP-1 activation. Unfortunately, little is known regarding the precise mechanisms involved in redox-mediated AP-1 gene expression. Because different antioxidants were used in these studies, it is possible that the loci of action of different forms of antioxidants may be specific to their chemical class. Likely, it is the ultimate subtle balance of intracellular redox potential that will determine the effect on AP-1 activity in response to either an oxidative or an antioxidant challenge. Clearly, additional studies are needed to clarify the role of AP-1 in antioxidant-mediated gene expression.
Redox Regulation of NF-B
NF-B is an inducible transcription factor complex composed of homodimeric or heterodimeric complexes of the Rel family of transcriptional activators. The predominant form of NF-B exists as a heterodimer of the p50 and p65 subunits. In unstimulated cells, NF-B is held in an "inactive" form by sequestration in the cytoplasm to the IB family of inhibitor proteins. Agents that activate NF-B induce specific phosphorylation events on IB via IB kinase activity, which direct IB to a ubiquitination/proteosomal degradation pathway. Degradation of IB thus unmasks the nuclear localization sequence of NF-B and allows NF-B to enter the nucleus and bind to specific DNA sequences in the regulatory regions of its target genes. 140 The NF-B transcription factor family controls the expression of a multitude of genes involved in inflammation and proliferation. Recent studies suggest the involvement of NF-B in a variety of acute and chronic inflammatory diseases such as sepsis, Crohn disease, and rheumatoid arthritis. 140 In addition, it is becoming increasingly apparent that NF-B is involved in the pathogenesis of proliferative disorders of the vasculature, including restenosis [141] [142] [143] and atherosclerosis. 144 Studies have shown that activated NF-B is present at increased levels in the fibrotic thickened intimamedia and atheromatous areas of atherosclerotic lesions, whereas little or no activated NF-B is detected in nondiseased vessels. 145 NF-B was also shown to be activated by an atherogenic diet 146 and by other cellular products believed to be involved in atherogenesis, including oxidized LDL 54, 147, 148 and AGE. 149 In addition, several of the cytokines and growth factors found in the atherosclerotic lesion, such as TNF-␣ and IL-1␤, activate NF-B in vitro in relevant cell types such as macrophages, SMCs, ECs, and lymphocytes. Furthermore, many of the genes that are regulated by NF-B encode for proteins such as TNF-␣, IL-1, macrophage colonystimulating factor (CSF), granulocyte CSF, granulocyte-macrophage CSF, MCP-1, tissue factor, VCAM-1, ICAM-1, and E-selectin, which function in regulating critical processes in atherogenesis. Cumulatively, these observations provide suggestive evidence for the role of NF-B in the pathogenesis of atherosclerosis.
Given the widely held hypothesis implicating redox imbalances in the pathogenesis of vascular disorders such as atherosclerosis and restenosis, it is not surprising that a substantial body of evidence indicates that activation of NF-B in vascular cells may be controlled by the redox status of the cell. 150 In fact, NF-B was the first eukaryotic transcription factor shown to respond directly to oxidative stress. A common step in all of the activation mechanisms that lead to IB degradation and NF-B nuclear translocation has been suggested to involve ROS. [151] [152] [153] [154] This conclusion was reached on the basis of the inhibition of NF-B activation by several chemically distinct antioxidants, including NAC, dithiocarbamates, vitamin E derivatives, GPx activators, and various metal chelators. Many reports now exist demonstrating inhibition of NF-B nuclear translocation by antioxidants, although the extent of this block appears to vary with the cell type and the nature of the signal.
Additional support for the involvement of ROS as a common activator of NF-B is provided by many studies demonstrating elevated levels of ROS by agents such as TNF-␣, IL-1␤, phorbol 12-myristate 13-acetate, UV light, ␥ rays, and lipid hydroperoxides. All of these agents are very potent NF-B-activating agents, and antioxidants have been shown to block both ROS production and resultant NF-B activation. Further support for an essential role of ROS in NF-B activation derives from experiments using exogenously added prooxidants. Initial pioneering work by Schreck et al, [151] [152] [153] among others, has shown that in some cells lines, H 2 O 2 and peroxide-containing molecules result in a rapid activation of NF-B. However, incubation with superoxide, hydroxyl radicals, or NO-generating compounds fail to cause activation, suggesting that like the prokaryotic redox-regulated transcription factor OxyR, NF-B activation is selectively mediated by peroxides. Conclusive support for a role of H 2 O 2 in NF-B activation came from studies in a catalase-overexpressing cell line that exhibited suppressed activation of NF-B in response to TNF-␣. 155 Addition of a catalase inhibitor restored the NF-B response. Also, overexpression of cytosolic SOD, which causes cytosolic H 2 O 2 accumulation, potentiated the NF-B response. Likewise, stimulation of GPx activity by selenium supplementation or GPx overexpression decreased NF-B activation induced by H 2 O 2 , IL-1␤, and TNF-␣. 156, 157 These observations broaden the scope for possible oxidants involved in NF-B activation from H 2 O 2 to a large variety of hydroperoxides and to the products generated by multiple LOs and cyclooxygenases, given that the classical GPx and the phospholipid hydroperoxide GPx have been shown to decrease the activity of cyclooxygenase, 158 5-LO, 159 and 15-LO. 160 Cumulatively, these observations have led to general agreement that NF-B activation is at least facilitated by some oxidative reactions.
The target molecules that are subject to redox regulation during NF-B activation remain unknown. It is unlikely that the NF-B subunits themselves are directly activated by oxidation, because only the reduced form of NF-B binds to DNA in vitro, 161 and attempts to activate isolated NF-B by oxidation in vitro were unsuccessful. 151 Direct oxidative inactivation of IB is also not likely to be involved in the redox regulation of NF-B, given that treatment of isolated NF-B/IB complexes with H 2 O 2 in vitro failed to dissociate IB or lead to NF-B DNA binding. 151, 162 Most evidence suggests that oxidative stresses induce, and antioxidants prevent, the cytoplasmic-nuclear translocation of NF-B. Therefore, the most likely scenario is that the signaling cascade leading to the phosphorylation and subsequent degradation of IB is regulated by redox processes. Indeed, it has recently been demonstrated that antioxidants inhibit IB kinase activity and prevent the phosphorylation and subsequent degradation of IB. 163, 164 Although the primary mechanism of activation of NF-B by ROS appears to be release from IB and its translocation to the nucleus, it is possible that ROS may modulate the activity of NF-B by regulating posttranslational modifications of the NF-B subunits themselves or of other transcriptional cofactors that influence the transcriptional activity of NF-B. Posttranslational modifications of NF-B subunits may influence (1) DNA binding affinity and/or specificity, (2) multimerization specificity with other NF-B subunits, or (3) transcriptional activity. Although phosphorylation has been shown to be important for some of these events, [165] [166] [167] no evidence exists to demonstrate a role of ROS in these processes. Clearly, however, understanding the role of redox processes in controlling the multitude of signaling events regulating the activity of NF-B will provide important mechanistic insights regarding redox modulation of transcriptional activity.
Peroxisome Proliferator-Activated Receptors
The PPARs are composed of members of the nuclear hormone receptor superfamily of transcription factors, a large and diverse group of proteins that mediate ligand-dependent transcriptional activation and repression. 168 PPARs are key players in lipid and glucose metabolism and are implicated in metabolic disorders predisposing to atherosclerosis, such as dyslipidemia and diabetes. Recent reports suggest that PPARs may play a role in inflammatory processes involved in the pathogenesis of atherosclerosis and restenosis by their ability to modulate monocytic gene expression. 169 -171 Furthermore, PPAR expression and functional activity have recently been observed in vascular cell types such as EC 172 and SMC. 173, 174 These studies suggest that PPARs may be viewed as redoxsensitive transcription factors in the vasculature by their ability to be selectively activated by oxidatively modified fatty acids.
PPAR␥ is one member of the PPAR family that has received considerable attention because of its role in regulating, among other things, energy balance and adipocyte differentiation. Identification of PPAR␥ as the receptor for the oral antidiabetic thiazolidinedione drugs linked this receptor to glucose homeostasis. 175, 176 Two recent reports suggest that PPAR␥ is involved in the development of monocytes along the macrophage lineage, in particular in the conversion of monocytes to foam cells. Tontonoz et al 177 demonstrated that oxLDL, but not the parent LDL particle, induced the expression of PPAR␥ in foam cells of atherosclerotic lesions. In addition, exposure of cells to PPAR␥ agonists increased the binding of oxLDL, but not of LDL. It was further shown that increased oxLDL binding was the result of increased expression of the scavenger receptor CD36, but not 2 of the other oxLDL receptors, scavenger receptor (SR)-A (SR-A) type I or type II. In a companion paper, 169 the nature of the endogenous ligand for PPAR␥ was examined, and it was shown that oxLDL, but not native LDL, could serve as an endogenous ligand for PPAR␥ and could stimulate PPAR␥-dependent transcription. This study identified the active components of the oxLDL particle as 9-and 13-hydroxyoctadenoic acid by demonstrating that these compounds themselves could mimic oxLDL with respect to monocyte maturation, PPAR␥ expression, PPAR␥-dependent transcription, and induced CD36 expression. Together, these studies point toward a direct role of oxLDL and components in the activation of PPAR␥-dependent gene expression and regulation of the oxLDL receptor, CD36. It remains to be determined whether activation by oxidized fatty acids plays a significant role in PPAR␥-mediated processes in other tissues. These observations suggest that activation of PPAR␥ by oxLDL in monocytes may contribute to foam cell conversion and thus potentiate early events in the pathogenesis of atherosclerosis.
In contrast to the proposed role of PPAR␥ in potentially proatherogenic events, it has recently been proposed that activation of PPAR␣ and PPAR␥ may mediate antiinflammatory responses in the vessel wall (Figure 2) . Two recent reports demonstrated that specific agonists of PPAR␥ suppress proinflammatory gene expression in monocytes. 170, 171 In addition, Staels et al 173 demonstrate that inflammatory responses in aortic SMCs (IL-1-induced production of IL-6, prostaglandin, and COX-2) is blocked by specific activators of the ␣ isoform of PPAR (PPAR␣), but not PPAR␥. Furthermore, Poynter and Daynes 178 demonstrated that activation of PPAR␣ in aged mice restored the cellular redox balance to that of young animals. This was evidenced by a lowering of tissue lipid peroxidation, elimination of constitutively active NF-B, and a loss in spontaneous inflammatory cytokine production after administration
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Redox Status and Vascular Gene Transcriptionof PPAR␣ activators. These effects were not observed in animals bearing a null mutation in PPAR␣. Also, administration of the antioxidant, vitamin E, to aged mice (that contain reduced levels of PPAR␣ mRNA) resulted in an elevated expression of PPAR␣ to levels seen in younger mice. This observation suggests that balancing the cellular redox state may provide a level of transcriptional regulation for PPAR␣. Taken together, these studies demonstrate that ligands for PPARs are effective in reducing levels of inflammatory cytokines and downstream markers of inflammation. It seems possible that suppression of these proinflammatory signals by PPAR-mediated inhibition of inflammatory gene expression may be one way to modulate or balance the oxLDL-mediated proinflammatory events associated with atherosclerosis. Thus, in a given cell, it is likely that the subtle balance between proinflammatory signals and suppression of these signals by transcriptional modulators (such as PPARs) will determine the inflammatory status of the cell. Future work is needed to clarify the role of oxLDL in PPAR-mediated signaling, especially in vascular cell types. Cumulatively, these studies implicate a role for oxidative processes (ie, oxidative modification of fatty acids) in activation of PPAR␥ and its potential involvement in disease processes such as atherosclerosis and restenosis. It will be interesting to determine what role chemical antioxidants and therapeutic strategies aimed at modifying PPAR function play in modulating PPAR-mediated molecular and cellular events both in vitro and in vivo.
Conclusion
Alterations in the cellular redox status modify DNA binding and transactivation activities of a variety of transcriptional activators. This, in turn, leads to changes in expression of a variety of target genes with ultimate changes in cell function. Redox regulation of gene expression, therefore, appears to be a robust regulatory system that allows cells to adapt to environmental changes. In the vasculature, this is no exception. In considering the pathogenesis of atherosclerosis, a strong body of data supports the notion that ROS generated in response to environmental and physical risk factors modulate the signal transduction processes ultimately leading to vascular inflammatory gene expression. Vascular inflammatory genes, such as VCAM-1, E-selectin, and MCP-1, represent a subset of genes implicated in the pathogenesis of atherosclerosis, and the regulation of these genes is characterized by a linkage between redox-sensitive signals and the nuclear regulatory apparatus. Mechanistically this might suggest that the proposed therapeutic benefits of antioxidants in atherosclerosis might be caused by alterations in the molecular regulation of gene expression of endothelial, smooth muscle, and inflammatory cells. Therefore, redox-sensitive regulation of vascular gene expression represents an intriguing paradigm for understanding not only the pathogenesis of atherosclerosis but also for the development of novel therapeutic treatment strategies. Hopefully, elucidation of precise redox-regulated signaling pathways as they relate to the expression of atherogenic genes will encourage the exploration of novel treatment modalities targeting these redox-sensitive pathways. This hypothesis establishes an important framework to begin to understand how modulation of the redox-sensitive signaling process may be used to specifically alter the expression of genes involved in the pathogenesis of a variety of diseases. PPAR␥, on the other hand, can modulate the proinflammatory effects of oxLDL signaling by suppressing inflammatory gene expression. 170, 171 In addition, oxLDL-mediated activation of PPAR␥ stimulates the transcription of the scavenger receptor for oxLDL receptor (CD36) on monocytes. Thus, activation of PPAR␥ and CD36 expression constitutes a positive feedback loop to potentiate the effects of oxLDL. Although some activators of PPAR␣ can mediate anti-inflammatory responses in SMCs, 173 to date it is not known whether oxLDL or its constituents can mimic this process. With respect to oxLDL-mediated inflammatory responses in the vasculature, it is likely that the subtle balance between the direct proinflammatory effects of oxLDL and the inhibitory properties of transcriptional regulators such as PPARs ultimately determines the inflammatory phenotype of the cell.
